Ignite Creation Date:
2024-05-06 @ 3:10 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04549870
Status:
COMPLETED
Last Update Posted:
2023-06-28
First Post:
2020-09-08
Brief Title:
Efficacy of Roflumilast in the Treatment of Psoriasis
Sponsor:
Bispebjerg Hospital
Organization:
Bispebjerg Hospital
Organization Data
Organization:
Bispebjerg Hospital
Class:
OTHER
Study ID:
H-20013697
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bispebjerg Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Mette Gyldenløve
Responsible Party Title:
MD PhD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Bispebjerg Hospital
Old Name:
None
Old Organization:
None